PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
Key facts
- Who runs it
- Vascutek Ltd.
- Where
- Allentown, Aurora, Cleveland, Columbus, Durham, Greenville, Indianapolis, Philadelphia, Richmond, and Tampa, United StatesSee the 10 sitesAlso in 5 other countries, 20 sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 17 Feb 2021
- Expected to end
- Jan 2037
- Type of study
- Observational, 5 groups
- Treatments tested
- Gelsoft Plus Vascular Graft
- Vascular Bypass Graft
- Cardiovascular Patch
- Gelweave Vascular Graft
- Gelweave Valsalva Vascular Graft
- Record updated
- 20 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients must meet all of the following inclusion criteria in order to be eligible for inclusion in the study:; All Patients:
- Patient meets the minimum age as per local regulations at time of consent
- Patient requires treatment with study device(s) according to the IFU(s)
- Patient is willing and able to comply with all SOC procedures and study visits
- Patient or their legally authorised representative (LAR) has given written informed consent to participate in study, including consent to collect data retrospectively; For prospective emergency patients, retrospective consent is permissible; For retrospective patients who are deceased at time of enrollment, local EC regulations relating to consent process should be followed; Retrospective Patients only:
- Patient has a minimum of 1 year post-operative follow-up data available, or complete data to death
- Patient implant date is no more than 5 years prior to study start date
Who cannot take part
- Any patient who meets any of the following exclusion criteria will be excluded from participation in the study:; Patient is unable or unwilling to comply with the SOC procedures or follow-up regime; Patient is contraindicated per the device IFU; Patient has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving this treatment and the procedures and evaluations pre- and post-procedure
Where in United States
Also in 5 other countries, 20 sites
- LeHigh Valley HospitalAllentown, United StatesContact: James WuTaking people
- University of Colorado AnschutzAurora, United StatesContact: Brett ReeceTaking people
- University Hospitals Cleveland Medical Center*Cleveland, United StatesContact: Terence SemenecTaking people
- Ohio State UniversityColumbus, United StatesContact: Kristine OrionTaking people
- Duke UniversityDurham, United StatesContact: Chad HughesTaking people
- East Carolina UniversityGreenville, United StatesContact: Eddie HillTaking people
- Indiana University HealthIndianapolis, United StatesContact: Joel Corvera, MDTaking people
- University of PennsylvaniaPhiladelphia, United StatesContact: Eric SuchanecTaking people
- Virginia Commonwealth UniversityRichmond, United StatesContact: Daniel Newton, MDTaking people
- University of South Florida - Tampa GeneralTampa, United StatesContact: Thanh TranTaking people
About the trial
What the trial wants to find out
The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice.
Read full original descriptionShow less
Data will be collected both retrospectively and prospectively.
The 5 groups in the trial
- Gelsoft Plus - Straights and Bifurcated
Patients with aneurysmal or occlusive disease, including those with connective tissue disorders who have received/will receive a Gelsoft Plus Straight or Bifurcate, implanted in the abdomen or peripheral arteries in the last 5 years and from study launch onwards.
Treatment: Gelsoft Plus Vascular Graft
- Gelsoft Plus - Extra-Anatomical
Any patients who have received/will receive a Gelsoft Plus Extra-Anatomical supported or unsupported graft, implanted for: axillary-femoral bypass, femoral-femoral bypass or femoral-popliteal bypass in the last 5 years and from study launch onwards.
Treatment: Vascular Bypass Graft
- Cardiovascular Patches - Gelseal, Gelsoft, Thin Wall
Patients who have been implanted with/require a cardiovascular patch for: thoracic vessel repair with a Gelseal Cardiovascular Patch; abdominal or peripheral vessel repair with a Gelsoft Cardiovascular Patch; or carotid endarterectomy with a Thin Wall Carotid Patch in the last 5 years and from study launch onwards.
Treatment: Cardiovascular Patch
- Gelweave - Abdominal, Thoracic, Thoracoabdominal
Patients who, due to either aneurysmal or occlusive disease, have had/require vascular repair of one of the following, implanted in the last 5 years and from study launch onwards: * Abdominal aorta, arteries arising from the abdominal aorta or peripheral arteries including femoral, iliac and popliteal arteries. * Thoracic aorta or arteries arising from the thoracic aorta. * Abdominal and thoracic aorta requiring a thoracoabdominal repair
Treatment: Gelweave Vascular Graft
- Gelweave - Valsalva
Patients who have had/require aortic root repair using valve sparing or valve replacing procedures, with or without replacement of the aortic arch, implanted in the last 5 years and from study launch onwards.
Treatment: Gelweave Valsalva Vascular Graft
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
- Record updated
- 20 August 2026